Trial group:Selinexor-containing Chemotherapy-free or Low-dose Chemotherapy Regimens

2 trials

Sponsors

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

Acute Myeloid LeukemiaRelapsed/Refractory Acute Myeloid Leukemia

Phase 4

Clinical study of selinexor-containing regimens in post-transplant AML patients who molecular relapse but failed after first-line preemptive treatment

RecruitingChiCTR2300077634

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAcute Myeloid Leukemia

Start: 2023-11-15Updated: 2023-11-21

Clinical study of Chemotherapy-free or Low-dose Chemotherapy regimen containing Selinexor in the treatment of relapsed/refractory acute myeloid leukemia

RecruitingChiCTR2300077623

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRelapsed/Refractory Acute Myeloid Leukemia

Start: 2023-11-15Updated: 2023-11-21